Erratum to: Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus (Modern Rheumatology doi:10.1007/s10165-009-0266-x);Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus

Modern Rheumatology

Volumn 20, Issue 3, 2010, Pages 291-294

  Morimoto, Shinji ^a   Watanabe, Tomoko ^a   Lee, Shouseki ^a   Amano, Hirofumi ^a   Kanmaru, Yutaka ^a   Ohsawa, Isao ^a   Tomino, Yasuhiko ^a   Takasaki, Yoshinari ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antineutrophil cytoplasmic antibody; Lupus nephritis; Rapidly progressive glomerulonephritis; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEROXIDASE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; TREATMENT OUTCOME;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; PEROXIDASE; TACROLIMUS; TREATMENT OUTCOME;

EID: 77956628766     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0278-6     Document Type: Erratum

References (15)

1. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2): 521-30. (Pubitemid 38130646)
2. Jennette JC, Xiao H, Falk RJ. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2006;17(5):1235-42. (Pubitemid 43673403)
3. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs. 2003;63(12):1247-97. (Pubitemid 36750952)
4. Mok CC, Tong KH, To CH, Siu YP, Au TC. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int. 2005;68(2):813-7. (Pubitemid 43323138)
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11): 1271-7. (Pubitemid 13221242)
7. Pirani CL, Olesnicky L. Role of electronmicroscopy in the classification of lupus nephritis. Am J Kidney Dis. 1982;2 (1 Suppl 1):150-63. (Pubitemid 13230787)
8. Akhtar M, al-Dalaan A, el-Ramahi KM. Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis. 1994;23(2):320-5. (Pubitemid 24075330)
9. Schwartz MM, Roberts JL, Lewis EJ. Necrotizing glomerulitis of systemic lupus erythematosus. Hum Pathol. 1983;14(2):158-67. (Pubitemid 13155878)
10. Sen D, Isenberg DA. Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus. 2003;12(9):651-8. (Pubitemid 37173660)
11. Kuster S, Apenberg S, Andrassy K, Ritz E. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Contrib Nephrol. 1992;99:94-8.
12. Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF. Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol. 1992;31(10):669-73.
13. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol. 1990;81(3):380-3. (Pubitemid 20273659)
14. Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med. 1990;113(9):656-63. (Pubitemid 20363637)
15. Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986;314(10): 614-9. (Pubitemid 16132725)